The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends higher on AstraZeneca, oil stock boost; Just Eat Takeaway slumps

Wed, 21st Apr 2021 09:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Just Eat Takeaway.com slips as Uber Eats plans German
launch

* UK inflation edges up as COVID-19 price hit begins to ease

* UK home prices jump at fastest rate in six years in
February

* FTSE 100 up 0.6%, FTSE 250 slips 0.1%
(Updates to close)

By Devik Jain and Shashank Nayar

April 21 (Reuters) - London's FTSE 100 rose on Wednesday,
led by gains in AstraZeneca and energy heavyweights BP and Royal
Dutch Shell, while Just Eat Takeaway.com dropped following Uber
Eats' plan to foray into the German market.

Drugmaker AstraZeneca gained 1.7% and was the top
boost to the FTSE 100 after India's Serum Institute said it
would sell AstraZeneca vaccine to private hospitals at
$8/dose.

The blue-chip index rose 0.5%, with oil majors
and adding 1.4% and 1.2% respectively, after
Azerbaijan's energy ministry said BP's oil output was 5.9
million tonnes in the first quarter.

Meanwhile, traders assumed a rise in inflation in March
would have little impact on monetary policy after data showed
British consumer price inflation rose to 0.7% in March, while
prices charged by manufacturers rose by 1.9%, the highest in
nearly two years.

"For the Bank of England ... the fact that inflation is
likely to rise this year while the economic outlook is improving
suggests little imminent need to look at negative interest
rates," said James Smith, an economist at ING.

"The less exciting inflation story for 2022 suggests
policymakers will be in little rush to tighten policy, which we
don't expect to happen before 2023."

The FTSE 100 has gained 6.7% year-to-date on optimism about
a speedy economic recovery from the pandemic-driven recession,
although weighing on sentiment are concerns that central banks
would tighten monetary policy sooner than expected on prospects
of rising inflation.

British house prices rose at the fastest annual rate in more
than six years in February, data showed, pushing construction
and material stocks up 0.8%.

Just Eat Takeaway.com fell 2.7% after a media
report about rival Uber Eats' plan to start a food delivery
service in Germany, one of Just Eats’ most lucrative markets.

Entain gained 2.2% after BetMGM, a U.S. joint
venture with MGM Resorts, said it was targeting net
revenue of $1 billion in 2022.
(Reporting by Devik Jain in Bengaluru; editing by Uttaresh.V
and Elaine Hardcastle)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.